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Abstract
Background: About 80% of new tuberculosis cases in Norway occur among immigrants from high incidence
countries. On arrival to the country all asylum seekers are screened with Mantoux test and chest x-ray aimed to
identify cases of active tuberculosis and, in the case of latent tuberculosis, to offer follow-up or prophylactic
treatment.
We assessed a national programme for screening, treatment and follow-up of tuberculosis infection and disease
in a cohort of asylum seekers.
Methods: Asylum seekers ≥ 18 years who arrived at the National Reception Centre from January 2005 to June
2006, were included as the total cohort. Those with a Mantoux test ≥ 6 mm or positive x-ray findings were
included in a study group for follow-up.
Data were collected from public health authorities in the municipality to where the asylum seekers had moved,
and from hospital based internists in case they had been referred to specialist care.
Individual subjects included in the study group were matched with the Norwegian National Tuberculosis Register
which receive reports of everybody diagnosed with active tuberculosis, or who had started treatment for latent
tuberculosis.
Results: The total cohort included 4643 adult asylum seekers and 97.5% had a valid Mantoux test. At least one
inclusion criterion was fulfilled by 2237 persons. By end 2007 municipal public health authorities had assessed 758
(34%) of them. Altogether 328 persons had been seen by an internist. Of 314 individuals with positive x-rays, 194
(62%) had seen an internist, while 86 of 568 with Mantoux ≥ 15, but negative x-rays (16%) were also seen by an
internist. By December 31st 2006, 23 patients were diagnosed with tuberculosis (prevalence 1028/100 000) and
another 11 were treated for latent infection.
Conclusion: The coverage of screening was satisfactory, but fewer subjects than could have been expected from
the national guidelines were followed up in the community and referred to an internist. To improve follow-up of
screening results, a simplification of organisation and guidelines, introduction of quality assurance systems, and
better coordination between authorities and between different levels of health care are all required.
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As tuberculosis (TB) in native populations in Western
countries decreases, the relative importance of cases
among immigrants increases. Latent tuberculosis is preva-
lent in immigrants, and may result in an increased inci-
dence for many years after immigration [1,2].
Many Western countries carry out screening immediately
after arrival, but programmes for immigrants from high
incidence countries vary widely between them, and their
documented impact is sparse. While some countries focus
mainly on diagnosing active pulmonary tuberculosis, oth-
ers follow up high risk individuals, or aim at preventing
new cases through BCG immunisation or treatment of
latent tuberculosis [3,4].
For public health it is most important to identify cases of
pulmonary tuberculosis and the majority of them can be
detected by chest x-ray [1,5]. Still many cases of extra-pul-
monary tuberculosis and latent tuberculosis may thus be
overlooked. A tuberculin skin test is often used in addi-
tion to x-ray, but has several limitations [6]. Recently, new
interferon gamma release assays have been introduced,
with promising results for diagnosing latent tuberculosis
and may become a useful addition to the screening pro-
gramme [7].
In Norway, the incidence of tuberculosis in the general
population gradually decreased until the late 1980's.
Thereafter the number of new cases has remained low and
was 6.3/100 000 population in 2006 [8]. During the last
25 years the characteristics of incident cases have changed,
and the active disease now stem from imported strains
rather than person to person transmission within the
country [9]. Somalia is the country of origin for most new
cases.
Previously, the main focus of the Norwegian tuberculosis
control programme was on early case detection of active
disease and follow-up without treatment of the latent
form. In 2002 the European working group on tuberculo-
sis control and elimination in low incidence countries
(WHO, International Union Against Tuberculosis and
Lung Disease, Royal Netherlands Tuberculosis Associa-
tion) recommended a new strategy. It aimed to reduce the
prevalence of tuberculosis infection and also included
prophylactic therapy [10].
The same year new regulations for tuberculosis control
were introduced in Norway. These emphasised a contin-
ued need to screen immigrants from high incidence coun-
tries after arrival, as well as others with high risk, and to
follow up those with abnormal findings [11]. The corre-
sponding national guidelines, that were issued by the
national health authorities to all health personnel
engaged in TB management and care, promoted more vig-
orous treatment of latent tuberculosis [12].
Public health care in Norway is organised in two levels
where the municipal authorities are responsible for pri-
mary health care. This includes infectious disease control
within the community. Patients in whom screening out-
come implies a more detailed and targeted follow-up, are
referred to specialist care in state-owned hospitals.
Recommended screening and management of tuberculosis
Asylum seekers and refugees (table 1) are subgroups of
immigrants with particularly high risk for tuberculosis
[13,14]. Hence, on arrival in Norway, all asylum seekers
are referred to the National Reception Centre outside Oslo
for registration, management of immediate medical
needs, and compulsory tuberculosis screening (figure 1
and table 2). Screening includes a Mantoux test and chest
x-ray for everyone over 15 years of age.
According to the guidelines, asylum seekers with a chest x-
ray suggestive of tuberculosis disease, as well as everyone
who reports symptoms of tuberculosis, should be referred
directly to the Central TB Clinic at Ullevaal University
Hospital, Oslo, for further examination. It is clearly stated
that in addition to a positive x-ray, a Mantoux test ≥ 15
mm should lead to a direct referral to an internist [12].
When leaving the National Reception Centre, asylum
seekers are directed to one of several local asylum seeker
centres or transit centres in communities throughout the
country. If an individual has to await the outcome of
examination, or if treatment is started, the whole family
will stay at one specially designated Transit Centre for TB
Treatment until the treatment is completed (figure 1).
Those who initially stay in a transit centre later move on
to an asylum seeker centre. On the other hand, they may
also leave the country on their own or be sent out at any
time. Sometimes, asylum seekers find private accommo-
dation on their own with help from family or others.
Screening results are mailed to the respective municipal
health authorities, and everyone with a Mantoux test of 6–
14 mm should be clinically examined in primary health
care and interviewed about other TB risk factors [12]. An
HIV test is not compulsory, but is taken if deemed clini-
cally relevant. Whenever definite risk factors are identi-
fied, all patients should be referred to an internist who is
responsible for ensuring timely clinical examination and
a sputum test, and any other relevant diagnostic work-up.
If tuberculosis disease is diagnosed or treatment for latent
tuberculosis is started, a nominal notification is sent to
the National Tuberculosis Register.Page 2 of 9
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Flow of asylum seekersigure 1
Flow of asylum seekers. Primary Health Care (PHC) form sent to first municipality (transit centres, asylum seeker centres, 
or private accommodation) 2: PHC form sent to second municipality (asylum seeker centres or private accommodation) 3: 
Specialist form sent to the Central TB Clinic and to other hospital based specialists (internists).
National Reception Centre
Screening with chest x-ray and Mantoux
Central TB Clinic3:
examination
Municipality 1
Transit Centre for TB 
Treatment1
Municipality 1
Private accomodation or
asylum seeker centre1
Specialist consultation3
Treatment
TB disease/
latent TB
National TB Register TB coordinator
Municipality 2/ private accommodation
or asylum seeker centre2
Suspected
TB disease
Disproved 
TB disease
Completed 
treatment
for TB disease
Moving to new municipality
TB 
disease
No treatment.
Follow up if latent TB
/ no follow up if no latent TB
Municipality 1
transit centre1
Moving to first municipality
from National Reception Centre
BMC Public Health 2009, 9:141 http://www.biomedcentral.com/1471-2458/9/141Information about asylum seekers is readily available
since they are all received through a single National
Reception Centre.
We aimed to assess to what extent the national recom-
mendations for screening, treatment and follow-up of
tuberculosis disease and infection among asylum seekers
had been implemented at the primary and specialist
health care levels in Norway [11,12].
Methods
Study population
All asylum seekers ≥ 18 years who arrived at the National
Reception Centre from January 2005 to June 2006, were
eligible for study inclusion except those that had left the
centre without a forwarding address, had left the country,
had been deported, or had died before leaving the centre.
Inclusion into the study group for follow-up was ascer-
tained from information held in the data base at the
National Reception Centre. The criteria for inclusion were
either a positive Mantoux test or a positive chest x-ray. The
former was defined as Mantoux ≥ 6 mm, (PPD: RT 23, 2
TU from SSI, Copenhagen, Denmark).
X-ray films were taken at the National Reception Centre
and interpreted by two independent readers, a pulmonol-
ogist and a radiologist. The results were later recoded for
this study. A positive x-ray included pleural pathology,
Table 1: Definitions of "asylum seeker" and "refugee"
Asylum seeker1 A person who on his or her own initiative, and without prior notification, asks the authorities in Norway for protection and 
recognition as a refugee. The person is called an asylum seeker until a decision has been made on the application.
Refugee A person who either has been granted residence permit before arrival, through the UN system, or arrived as an asylum 
seeker and has been granted protection as refugee after application.
1http://www.udi.no/upload/English/FactSheet/FaktaarkAsylEngelsk.pdf
Table 2: Kind and characteristics of institutions attending asylum seekers
Institutions 
(total number)
Functions Health care level Staff Source of information 
for the study
National Reception 
Centre (1)1
Short term.
All asylum seekers (AS) on 
arrival to Norway. 
Screening by chest x-ray 
and Mantoux.
Primary health care (PHC) 
paid for by national
government.
PHC officer or nurse Information from the 
computer system of the 
National Reception 
Centre.
TB Treatment Transit 
Centre (1)1
Short or long term. 
Treatment of patients with 
active TB, or potential 
patients waiting for 
consultation or 
examination results. Family 
members are included.
PHC paid for by national
government
PHC officer or nurse Filled in PHC registration 
forms2
Central TB Clinic (1)1 Out patient.
AS referred directly from 
the National Reception 
Centre or from other 
levels. Focus is active TB.
Hospital based specialist 
health care.
Specialists in pulmonary 
medicine
Filled in specialist 
registration form3
Transit centre (4)1 Short term stay. AS who 
wait for an interview by 
police or for being 
deported.
PHC paid for by national
government
PHC officer or nurse Filled in PHC registration 
forms2
Asylum seeker centre 
(ca 100, January 2005)
Longer stay. Staying there 
till they get a permanent 
residency or are deported.
Municipal authorities 
directly responsible for 
health care.
PHC officer or nurse Filled in PHC
registration forms2 or 4
Specialist health care Out patient.
Examine and treat AS after 
referral from primary 
health care
Hospital based specialist 
care.
Hospital specialists, 
pulmonary or internal 
medicine
Filled in specialist
registration form3
1: Number of centres, 2: PHC forms sent to the first municipality after the National Reception Centre, 3: Specialist forms, 4: PHC forms sent to the 
second municipality after the National Reception CentrePage 4 of 9
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chymal pathology.
An interferon gamma release assay test (QuantiFERON®
TB Gold in-tube test, Cellestis Ltd, Carnegie, Victoria, Aus-
tralia, QFT) had been performed in a previous study of a
subset of 912 eligible persons [15].
Data collection
Information on demographics and initial screening
results was collected from the data base at the National
Reception Centre. Follow-up information was obtained
by using two different study forms. First, a local primary
health care (PHC) form was sent to the public health phy-
sician in the municipality where the asylum seekers had
moved to. If the person in question had moved to a sec-
ond municipality, the same form was sent there (figure 1).
Second, a specialist form was sent to the Central TB Clinic
whenever findings at the National Reception Centre had
indicated that a referral was indicated. It was sent to other
hospital internists throughout the country when the PHC
form positively confirmed that an individual had been
referred to specialist care (figure 1).
Both forms collected information about demographics,
registration and flow of information, previous history and
other diseases, TB risk factors, symptoms, clinical exami-
nation and findings, plans for follow-up or referrals, and
relocations of study participants. The municipalities were
asked whether the asylum seeker had been examined or
interviewed, and if so, by whom: physician, community
health nurse, or regular nurse. Any referrals were recorded:
x-rays, specialist health care, or others. In case of no refer-
ral, the reason why was recorded: not indicated, the
patient did not want a referral, or other reasons. Relevant
dates and numbers were also recorded.
Name and birth date on everyone included in the study
group were checked against the National Tuberculosis
Register. The latest update of the register took place on
December 31st 2006.
Data handling and analysis
Study forms were scanned and entered into SPSS for Win-
dows, version 14 (Chicago, IL, USA). Comments and
administrative information were coded manually and
entered to the same data file.
Frequencies were analyzed with proportions and 95%
confidence intervals (CI). Groups were compared on
demographics, and positive x-rays were also compared on
x-ray codes. Prevalence < 0.05 were considered statistically
significant.
Study ethics
The Regional Committee for Medical Research Ethics
approved the study. The Norwegian Data Inspectorate, the
Directorate for Health and Social Affairs, the Ministry of
Labour and Social Inclusion, and the Research Committee
at Ullevaal University Hospital all gave their permission.
Results
Among the 5112 asylum seekers ≥ 18 years who arrived at
the National Reception Centre from January 2005 to June
2006, 4643 (91%) were eligible for study inclusion and
are hereafter referred to as the total cohort. Among this
cohort, there were 3222 (69%) males and 3333 (72%)
were in the 18–34 year old age group. They came from 90
different countries, and Iraq, Somalia, Russia, Afghani-
stan, and Serbia and Montenegro contributed most, i.e.
2434 persons (52%). Coverage of a valid Mantoux test
was 4526 (97.5%), the yield of a Mantoux ≥ 6 mm was
2127 (46%) and a positive chest x-ray 323 (7%) individ-
uals, respectively. A positive QFT test was used as the only
inclusion criterion for 28 participants.
The follow-up study group
Of the 2293 asylum seekers with at least one positive
inclusion criterion, 2237 were included in the follow-up
study because 56 individuals who were eligible for inclu-
sion had left the National Reception Centre with no for-
warding address, left the country, been deported, or died
before leaving the centre.
The proportion of males was higher in the youngest age
group. More participants came from Europe and Asia in
the older age group while there were more Africans in the
youngest one. The five most frequent countries of origin
were the same as in the total cohort.
Registration forms to local municipalities were sent to 81
different asylum seekers centres. From January 2005 to
January 2007 there was a reduction in the number of asy-
lum centres from 100 to 65, i.e. many centres that were
contacted initially, closed down during the study period.
We received information about 1625 (73%) of those asy-
lum seekers who had moved out into the municipalities,
and 220 (93%) of those who had been referred to special-
ists (figure 1).
Study end points
Among 1326 persons with negative x-rays and a Mantoux
test result between 6 and 14 mm, 372 (28%) were seen in
PHC, of whom 188 of 572 (33%) Africans were seen,
compared to 45 of 221 (20%) Europeans and 129 of 494
(26%) Asians. Of the 568 persons with negative x-ray and
Mantoux ≥ 15 mm, 86 (16%) were seen by an internist. Of
all the observed proportions, the differences between Afri-Page 5 of 9
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was the only one that was statistically significant (p <
0.05).
Further, of the 314 persons with abnormal x-ray findings,
194 ones (62%) were seen by an internist. While 165 of
235 (70%) with parenchymal findings were seen, 20 of 61
(33%) of those with other x-ray findings were seen and
the differences were statistically significant (p < 0.05).
Among subjects with positive x-rays, 76 of 115 (66%)
Africans, 73 of 128 (57%) Asians and 38 of 55 (69%)
Europeans were seen and the proportions were not signif-
icantly different.
Altogether 758 were assessed in one way or another in
PHC (figure 2). Of these, 673/2237 (30%) persons had
actually been seen by a physician (n = 380) or nurse (n =
293) at this care level. Another 85 persons were referred
directly from PHC either for chest x-ray or to a specialist
without being seen personally.
Personal encounters took place a median of 9 weeks after
arrival (range 0–124). Thus, 302 of 439 (69%) persons
with valid dates were seen within 13 weeks of arrival and
376/439 (86%) within 26 weeks.
Three hundred and twenty-eight persons, i.e. 15% of the
study group, were seen by an internist. They included 185
persons who were either examined at the Central TB
Clinic and/or 169 who were examined by other hospital
internists (figure 2). In all 236 persons were referred from
PHC to an internist. Median time from arrival in the coun-
try to the internist visit was 25 weeks (range 0–114). The
median time from the referral letter was received till the
internist consultation took place was 10 weeks.
A total of 794 patients (35% of the study group) were seen
either by primary and/or secondary health care providers.
When the cohort of 2237 asylum seekers were matched
with the National Tuberculosis Register (31st December
2006), 23 (1028/100 000) cases of active tuberculosis
were identified. Thirteen were diagnosed within 3 months
of arrival, 14 within 6 months, and 19 within 12 months.
Of those cases, 11 were from Somalia, three from Russia
and two from Serbia and Montenegro. Four cases were
reported among the 27% of asylum seekers with no reply
from PHC, one was seen at the Central TB Clinic, while
the other three were diagnosed five, 17 and 33 weeks after
arrival. We further identified 11 cases who had started
treatment for latent tuberculosis, all had a Mantoux test ≥
10 mm, and seven came from Africa.
Discussion
Of 4643 asylum seekers, tuberculosis screening identified
2237 persons (48%) who should have been assessed and
followed up by primary or specialist health care. Between
6–24 months after arrival, only one third of those at high
risk had been assessed by community health care, while
15% had seen an internist. Twenty-three persons were
diagnosed with tuberculosis disease and 11 had started
treatment for latent tuberculosis.
Limitations of the study
The study design implied that information about assess-
ment and referrals depended on an initial response from
PHC. The lack of response clearly reduced the number
brought to our attention about asylum seekers who were
referred to and seen by a specialist. Information collected
through the study forms was limited to what we could
retrieve from patient records. Thus, if records were not
found or were incomplete, the numbers assessed and/or
referred could be too low.
We do not know if the 27% with no response from PHC
were assessed and followed-up to the same degree as those
with a response. One possibility is, on the whole, that
municipalities that did not respond were less interested in
TB than those that did.
Total numbers of asylum seekers with an indication for fol-low-up of TB creening se n or assessed i  Norwegian primary and/or speci list health ca e cf. t xtFigure 2
Total numbers of asylum seekers with an indication 
for follow-up of TB screening seen or assessed in 
Norwegian primary and/or specialist health care cf. 
text.
Study population
at the National Reception 
Centre
N=2237
Asessed in primary
health care
N=758 (673 seen and
85 referred directly)
Seen by 
specialist 
after referral
N=169
Seen by specialist
at the Central TB
Clinic
N=185
Totally seen
by specialist
N=328
Totally seen 
by primary and/or 
specialist health
care N=794Page 6 of 9
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leaving the country, and if the interval before they did so
made any difference to our results. This limits our poten-
tial to give exact rates for those that should have been seen
in PHC or by a specialist. Because of insufficient registra-
tion, and since the systems for handling follow-up of
screening results and referrals due to symptoms are mixed
together, we cannot say exactly how many of the TB cases
were found through the screening system or through refer-
rals because of symptoms. We are also unable to assess the
incidence of TB at certain times after arrival. If many had
left at an early stage, the denominators would decrease,
with a consequent increase in rates. Dates for assessment
or referral were often left open on the forms or were obvi-
ously incorrect.
Because asylum seekers do not have a personal identifier,
the cases found through the match with the TB Register
could have been reduced, and this may also have reduced
the numbers of study individuals recorded in the munici-
palities and hospitals to where the study forms were sent.
Apparently, this would limit both their compliance to
national guidelines and the numbers found through the
TB Register.
Several local authorities could not provide health records
for asylum seekers who had moved on, or where asylum
seeker centres had been abandoned during the study
period. This also limited the quality of our study.
Study endpoints
The entry screening was satisfactory and only 2.5% of asy-
lum seekers had no registered Mantoux result. Voluntary
screening at a similar centre in the UK reported that 94%
were screened [16]. Most of the 469 asylum seekers who
were not included in the total cohort left the country or
were deported straight away and were of limited interest
from a screening point of view. The number of the total
cohort who actually got an x-ray taken, was impossible to
retrieve from the data recording system at the National
Reception Centre.
Everybody with a Mantoux 6–14 should have been seen in
PHC, but only 28% of them were. Informal information
given as reasons for this insufficient follow-up, were an
absence of personal information (wrong address, name or
date of birth), lack of resources, low priority, and insuffi-
cient knowledge of the guidelines or how they should be
interpreted. Sometimes, patients were referred separately
to x-ray, but not to a specialist. That procedure was appro-
priate given the previous guidelines, but not the current
ones [11]. It took a median time of 9 weeks from arrival
in Norway until assessment took place, but the range was
0–124 weeks. Thus, we speculate that several asylum seek-
ers were not assessed unless they developed symptoms
which brought them to the attention of the health author-
ities.
Follow-up of x-ray findings is the most important part of
the screening, and we found that only 62% of those with
initial positive findings were seen by an internist. This was
most likely an organisational problem between the
National Reception Centre and the Central TB Clinic.
There was most probably some selection of follow up at
the Central TB Clinic since relatively more cases with
parenchymal findings were seen by an internist.
The guidelines recommend that all cases with Mantoux ≥
15 mm should be referred directly to an internist, but they
do not specify if the individual should be seen at the Cen-
tral TB Clinic or at the nearest institution after they have
moved to their new home municipality. Only 16% of
those with Mantoux ≥ 15 mm were finally seen by an
internist. Generally, they were not referred to the Central
TB Clinic, and arguments such as an expected short stay at
the National Reception Centre, the general high workload
at the Central TB Clinic, and uncertainty about how long
the asylum seekers would stay in the country were used to
explain this. However, these subjects were not referred to
a specialist after they had arrived in their new municipal-
ity, either.
The median time from the referral letter was received until
the specialist consultation took place was 10 weeks. This
seems appropriate if the question was an assessment for
latent TB, but not if the question was to rule out active dis-
ease.
We matched study group individuals with the National
Tuberculosis Register which allowed us to estimate point
prevalence and an incidence rate. However, since many
asylum seekers could have left the country without notifi-
cation, this limited the exact population at risk. It also
made it difficult for both health care levels to follow up
the initial cohort. Conversely, these limitations realisti-
cally mimic the complexity of information flow and refer-
ral data for this group of individuals.
We identified 23 cases (1%) of the study group with tuber-
culosis disease between 6 to 24 months after arrival. Some
incident cases that occurred after screening may have been
mixed up with the prevalent ones, and we are unable to
estimate how many cases of active TB we missed through
lack of adherence to the guidelines. Studies from other
countries have reported prevalences of between 0.1–1.2%
[13,16-18], but valid comparisons between our and other
studies require more information about the different
study populations.Page 7 of 9
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TB was lower than expected and potential reasons for this
will be discussed in a forthcoming paper. National guide-
lines vary between countries, yet other studies show a lack
of adherence to guidelines similar to ours [19,20]. Com-
parisons between studies are made even more difficult
because treatment indications for latent TB vary consider-
ably.
Information flow and data ascertainment
An overall problem was that the flow of health informa-
tion between administrative levels did not keep up with
the movements of individual asylum seekers. Similar dif-
ficulties have been reported by others and compare well
with our results [19-21].
Lack of adequate information between asylum seeker cen-
tres and primary or specialist health care was another
problem we identified.
Personal characteristics
Asylum seekers are registered with their name and date of
birth on arrival, but do not get the personal identifier all
Norwegian residents have until they have stayed in the
country for several months. As a result of registration
errors or because their name or date of birth are misstated,
an asylum seeker may have several different identities and
is not recognised in many public registers. Also, some may
have entered Norway several times during the study
period, resulting in a further negative influence on assess-
ment or treatment. All these factors made follow-up quite
difficult.
Asylum seekers move several times and frequently with-
out reporting or informing authorities about their new
address. They usually have little knowledge of the Norwe-
gian language, their access to an interpreter is limited, and
they may have a different conception of health issues. All
are reasons why appointments were not kept.
Consequences for policy
Despite our current and detailed guidelines, we may spec-
ulate that the inadequate follow-up was due to a complex
organisation, insufficient or inappropriate information
handling procedures, insufficient awareness and adher-
ence to the guidelines, and limited focus on the TB issue
by the involved health care providers and society at large.
Further data analyses may cast light on some of these
assumptions.
We believe that both the organisation and the guidelines
should be simplified. Furthermore, a quality assurance
and a report system for information flow and personal fol-
low-up are needed. Cooperation between immigration
and health authorities should make sure that municipali-
ties with asylum seekers centres have a more streamlined
and efficient system for follow-up of tuberculosis screen-
ing with special staff dedicated to implementing it.
Conclusion
TB screening of asylum seekers identified a prevalence of
1% of active tuberculosis in the study group included for
follow-up. In addition we found a considerable propor-
tion of subjects at increased risk. We identified inadequate
handling of screening results at all levels of care, with too
few patients treated for latent tuberculosis.
To improve follow-up of screening results, a simplifica-
tion of organisation and guidelines, introduction of qual-
ity assurance systems, and better coordination between
authorities and between different levels of health care are
all required.
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TB: Tuberculosis; QFT: QuantiFERON®TB Gold; PHC: Pri-
mary Health Care.
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